Published in Eur Respir J on February 01, 2007
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study. Lancet Respir Med (2015) 5.92
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax (2008) 4.79
Varenicline for tobacco dependence. N Engl J Med (2008) 2.70
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Clinico-epidemiological profile of tobacco users attending a tobacco cessation clinic in a teaching hospital in Bangalore city. Lung India (2012) 1.20
Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health (2011) 1.13
Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm (Lond) (2010) 1.13
Varenicline in the treatment of tobacco dependence. Neuropsychiatr Dis Treat (2008) 1.03
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*. Multidiscip Respir Med (2014) 0.97
Differential assessment and management of asthma vs chronic obstructive pulmonary disease. Medscape J Med (2009) 0.91
Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med (2013) 0.91
Pneumocafé project: an inquiry on current COPD diagnosis and management among General Practitioners in Italy through a novel tool for professional education. Multidiscip Respir Med (2014) 0.88
Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD. Lung (2008) 0.85
Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention. Dtsch Arztebl Int (2009) 0.85
Effective smoking cessation interventions for COPD patients: a review of the evidence. JRSM Short Rep (2011) 0.82
Effectiveness of smoking cessation using motivational interviewing in patients consulting a pulmonologist. Tuberc Respir Dis (Seoul) (2014) 0.81
Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis. BMC Fam Pract (2015) 0.81
Tobacco cessation outcomes in a cohort of patients attending a chest medicine outpatient clinic in Bangalore city, southern India. Indian J Med Res (2014) 0.81
Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med (2012) 0.80
Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging. Chest (2014) 0.79
Effectiveness of regular reporting of spirometric results combined with a smoking cessation advice by a primary care physician on smoking quit rate in adult smokers: a randomized controlled trial. ESPIROTAB study. BMC Fam Pract (2011) 0.79
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. BMC Public Health (2007) 0.78
The Gap between Tobacco Treatment Guidelines, Health Service Organization, and Clinical Practice in Comprehensive Cancer Centres. J Oncol (2011) 0.77
Real-world comparative study of behavioral group therapy program vs education program implemented for smoking cessation in community-dwelling elderly smokers. Clin Interv Aging (2015) 0.76
Air pollution and chronic airway diseases: what should people know and do? J Thorac Dis (2016) 0.76
A new instrument to predict smoking cessation among patients with chronic obstructive pulmonary disease: an observational longitudinal study of the Trying To Quit smoking questionnaire. NPJ Prim Care Respir Med (2016) 0.75
The Effect of a Training Program on Oral Health and Behavior Change in Asthma Patients. Balkan Med J (2016) 0.75
Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis. Tob Induc Dis (2016) 0.75
Standards of suitability for the management of chronic obstructive respiratory diseases. Multidiscip Respir Med (2014) 0.75
Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study. NPJ Prim Care Respir Med (2017) 0.75
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. Int J Chron Obstruct Pulmon Dis (2009) 0.75
Inflammation and pathological damage to the lungs of mice are only partially reversed following smoking cessation on subacute exposure to cigarette smoke. Mol Med Rep (2015) 0.75
A pilot randomized controlled trial of smoking cessation in an outpatient respirology clinic. Can Respir J (2015) 0.75
Smoking Cessation Advisory Intervention in Patients with Cardiovascular Disease. Med Arch (2017) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav (1978) 9.23
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Beneficial effects of nicotine: fact or fiction? Addiction (1993) 6.59
Use of lacZ fusions to delimit regulatory elements of the inducible divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 6.23
THE PEPTASE, LIPASE, AND INVERTASE OF HEMOLYTIC STREPTOCOCCUS. J Exp Med (1922) 6.01
Activity of Vitamin B12 in Addisonian Pernicious Anemia. Science (1948) 5.93
Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax (1998) 4.95
Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. Thorax (1998) 4.43
With nurse practitioners, who needs house officers? BMJ (1995) 4.16
Tobacco industry tactics for resisting public policy on health. Bull World Health Organ (2000) 4.04
Non-attendance or non-invitation? A case-control study of failed outpatient appointments. BMJ (1989) 3.50
Road traffic and adverse respiratory effects in children. SIDRIA Collaborative Group. Occup Environ Med (1998) 2.68
NITROGEN RETENTION, CREATINURIA, AND OTHER EFFECTS OF THE TREATMENT OF SIMMONDS' DISEASE WITH METHYL TESTOSTERONE. J Clin Invest (1943) 2.51
Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control (2008) 2.48
Definition, epidemiology and natural history of COPD. Eur Respir J (2007) 2.47
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46
Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict (1987) 2.33
Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med (1999) 2.31
Smoking cessation: evidence based recommendations for the healthcare system. BMJ (1999) 2.26
Effects of nicotine chewing gum and follow-up appointments in physician-based smoking cessation. Prev Med (1984) 2.21
How to predict exacerbations and hospital admissions in stable COPD outpatients. Respiration (2000) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Cassini observes the active south pole of Enceladus. Science (2006) 2.15
Psychological interventions for coronary heart disease. Cochrane Database Syst Rev (2004) 2.14
The action of curarine on the respiratory mechanism. J Physiol (1938) 2.12
The sand seas of Titan: Cassini RADAR observations of longitudinal dunes. Science (2006) 2.11
Importance of baseline cotinine plasma values in smoking cessation: results from a double-blind study with nicotine patch. Eur Respir J (1996) 2.03
A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med (1982) 2.01
Nicotine replacement: a new approach to reducing tobacco-related harm. Eur Respir J (1998) 2.01
The lakes of Titan. Nature (2007) 1.97
Increasing COPD awareness. Eur Respir J (2006) 1.94
The impact of parental smoking on asthma and wheezing. SIDRIA Collaborative Group. Studi Italiani sui Disturbi Respiratori nell'Infanzia e l'Ambiente. Epidemiology (1999) 1.90
The impact of climate and traffic-related NO2 on the prevalence of asthma and allergic rhinitis in Italy. Clin Exp Allergy (2002) 1.87
Do clinical trials improve quality of care? A comparison of clinical processes and outcomes in patients in a clinical trial and similar patients outside a trial where both groups are managed according to a strict protocol. Qual Saf Health Care (2005) 1.85
Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol (1995) 1.84
Recommendations for epidemiological studies on COPD. Eur Respir J (2011) 1.84
Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM (1996) 1.81
Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration (2005) 1.81
Shoulder pain in wheelchair users with tetraplegia and paraplegia. Arch Phys Med Rehabil (1999) 1.80
Chlamydia: One step forward or two backwards? BMJ (1988) 1.75
Enceladus' water vapor plume. Science (2006) 1.72
Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet (1990) 1.71
Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. Addiction (2010) 1.69
Newly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment options. BMJ (2001) 1.68
Disseminated Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome mimicking Whipple's disease. Gastroenterology (1983) 1.67
Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction (2001) 1.67
Signal-detection analysis of group decision making. Psychol Rev (2001) 1.65
Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J (2005) 1.65
Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins. Proc Natl Acad Sci U S A (1985) 1.65
Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration (2001) 1.63
Do social support interventions ("buddy systems") aid smoking cessation? A review. Tob Control (2000) 1.62
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest (2000) 1.60
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
Smoking cessation activities by general practitioners and practice nurses. Tob Control (2001) 1.53
Particulate matter from tobacco versus diesel car exhaust: an educational perspective. Tob Control (2004) 1.52
Cessation of long-term nicotine gum use--a prospective, randomized trial. Addiction (1995) 1.47
Slowing the speedy. BMJ (1988) 1.47
Regular smokers, lifetime very light smokers, and reduced smokers: comparison of psychosocial and smoking characteristics in women. Health Psychol (1995) 1.47
Rectal cancer: changing patterns of referral for radiation therapy 1982-1997. Aust N Z J Surg (2000) 1.46
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia (1998) 1.42
Acute respiratory distress syndrome among trauma patients: trends in ICU mortality, risk factors, complications and resource utilization. Intensive Care Med (2001) 1.42
Late whiplash syndrome: a clinical and magnetic resonance imaging study. Funct Neurol (2000) 1.41
Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J (2010) 1.41
Conformations of linear chains. Systematics and suggestions for nomenclature. Acc Chem Res (2000) 1.41
Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int J Tuberc Lung Dis (2000) 1.41
[Cost of ICU in Italy. Results from an empirical study on a sample of 12 hospitals]. Minerva Anestesiol (2001) 1.40
How to intervene against smoking. J R Coll Physicians Lond (2000) 1.39
What is the effect of penicillin dosing interval on outcomes in streptococcal infective endocarditis? J Antimicrob Chemother (2013) 1.39
Evaluation of the impact of guidelines on tuberculosis control in Italy. National AIPO "Tuberculosis" Study Group. Associazione Italiana Pneumologi Ospedalieri. Monaldi Arch Chest Dis (1996) 1.39
Cardiac rehabilitation. Eur Heart J (1999) 1.38
Smoke-free homes in England: prevalence, trends and validation by cotinine in children. Tob Control (2009) 1.36
Thrombocytopenia associated with administration of trimethoprim/sulfadiazine in a dog. J Am Vet Med Assoc (1992) 1.35
Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol (1988) 1.35
Rain, winds and haze during the Huygens probe's descent to Titan's surface. Nature (2005) 1.34
Indoor air pollution and airway disease. Int J Tuberc Lung Dis (2004) 1.31
Assessing the functional status during an asthma attack with Dartmouth COOP charts. Validity with respect to the change in asthma. Fam Pract (1991) 1.31
Private health insurance and medical care utilization: evidence from the Medicare population. Inquiry (1991) 1.30
Behavioral correlates of individual differences in road-traffic crash risk: an examination method and findings. Psychol Bull (1993) 1.29
[T.P.I. test and blastic transformation of lymphocytes in vitro]. Minerva Dermatol (1967) 1.26
Childhood cancer mortality: international comparisons 1955-1974. World Health Stat Q (1984) 1.26
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking. Drug Alcohol Depend (2012) 1.24
Spatiotemporal analysis of experimental differences in event-related potential data with partial least squares. Psychophysiology (2001) 1.22
Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med (1995) 1.22
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis (2014) 1.22
Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest (1995) 1.22
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Non-admission or non-invitation? A case-control study of failed admissions. BMJ (1989) 1.22
A randomized, controlled trial of child psychiatric assessments conducted using videoconferencing. J Telemed Telecare (2000) 1.21
The effect of speed cameras on injuries from road accidents. BMJ (1998) 1.21
Molecular cloning and sequence of the gene for outer membrane protein P5 of Haemophilus influenzae. Infect Immun (1993) 1.19